ACSH staffers are doubly impressed with the FDA today. Regulators have advised parents to continue medicating their children for ADHD despite the risk of sudden death suggested by a study that used questionable methods.
This is a legitimate benefit-risk analysis by the FDA, says ACSH s Dr. Gilbert Ross. The study [to which they are reacting] used dubious methods and argued from inconclusive data. The FDA should be applauded for saying that this is not a cause and effect study and parents should not change their children s drug regimen.
In yet another display of regulatory competence, the FDA has been targeting websites that peddle fraudulent swine flu prevention and treatment products. We are committed to aggressively pursuing those who attempt to take advantage of a public health emergency by promoting and marketing unapproved, uncleared, or unauthorized products, said FDA chief Margaret A. Hamburg, in a news release yesterday.
These are red-letter achievements for the FDA in the battle against bad science. Two cheers for the FDA, declares Dr. Ross.
